Open original FDA record ↗Recall record
- FDA identifier
- Z-0576-06
- Company in FDA record
- Nova Biomedical Corporation
- FDA classification date
- Feb 28, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Analyzers may fail to perform scheduled automatic two-point calibrations and Quality Control runs
Source facts
- Action
- Nova Biomedical Issued on 1/27/2006 an Advisory Notice to Stat Profile CCX Customers to report the malfunction and request the Good Laboratory Practices (GLP) be used and review be made to assure the calibration status and QC is being performed. A new software version is scheduled to be released to correct the error.
- Initiated
- 2006-01-27
- Root cause
- Other
- Terminated
- 2006-10-19
- Distribution
- Nationwide Foreign: Canada, UAE, Taiwan, Singapore, Budapest, UK, France, Malaysia, France, Mexico, Korea, Finland, Germany, Turkey, Ireland, Italy, Austria, Australia, Netherlands, Venezuela, Japan, Greece, Thailand, Israel, Spain, China, Hong Kong, Argentina, Czech Republic, Croatia,Trinidad WI
- Recall number
- Z-0576-06
- Recall status
- Terminated
- CDRH record ID
- 44009
- FDA classified
- 2006-02-28
- Recall event number
- 34522